Alan Colowick - Net Worth and Insider Trading
Alan Colowick Net Worth
The estimated net worth of Alan Colowick is at least $0 dollars as of 2024-11-07. Alan Colowick is the Director of Principia Biopharma Inc and owns about 0 shares of Principia Biopharma Inc (PRNB) stock worth over $0. Details can be seen in Alan Colowick's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alan Colowick has not made any transactions after 2020-07-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alan Colowick
Alan Colowick Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alan Colowick owns 8 companies in total, including Principia Biopharma Inc (PRNB) , Personalis Inc (PSNL) , and Dimension Therapeutics Inc (DMTX) among others .
Click here to see the complete history of Alan Colowick’s form 4 insider trades.
Insider Ownership Summary of Alan Colowick
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PRNB | Principia Biopharma Inc | 2020-09-28 | director |
PSNL | Personalis Inc | 2019-06-19 | director |
DMTX | Dimension Therapeutics Inc | 2017-11-07 | director |
2017-06-14 | director | ||
2006-10-16 | President & Oncology | ||
2005-02-03 | Chief Medical Officer | ||
2021-03-24 | director | ||
2023-05-04 | director |
Alan Colowick Latest Holdings Summary
Alan Colowick currently owns a total of 1 stock. Alan Colowick owns 0 shares of Principia Biopharma Inc (PRNB) as of July 1, 2020, with a value of $0.
Latest Holdings of Alan Colowick
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PRNB | Principia Biopharma Inc | 2020-07-01 | 0 | 100.05 | 0 |
Holding Weightings of Alan Colowick
Alan Colowick Form 4 Trading Tracker
According to the SEC Form 4 filings, Alan Colowick has made a total of 2 transactions in Principia Biopharma Inc (PRNB) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Principia Biopharma Inc is the sale of 7,500 shares on July 1, 2020, which brought Alan Colowick around $450,000.
Insider Trading History of Alan Colowick
- 1
Alan Colowick Trading Performance
Alan Colowick Ownership Network
Ownership Network List of Alan Colowick
Ownership Network Relation of Alan Colowick
Alan Colowick Owned Company Details
What does Principia Biopharma Inc do?
Who are the key executives at Principia Biopharma Inc?
Alan Colowick is the director of Principia Biopharma Inc. Other key executives at Principia Biopharma Inc include Chief Medical Officer Dolca Thomas , Chief Development Officer Stefani Wolff , and Chief Scientific Officer David M Goldstein .
Principia Biopharma Inc (PRNB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Principia Biopharma Inc Insider Transactions
Alan Colowick Mailing Address
Above is the net worth, insider trading, and ownership report for Alan Colowick. You might contact Alan Colowick via mailing address: C/o Threshold Pharmaceuticals, Inc., 1300 Seaport Boulevard, 5th Floor, Redwood City Ca 94063.